|
1
|
Ajani JA, Bentrem DJ, Besh S, D'Amico TA,
Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, et
al: Gastric cancer, version 2.2013: Featured updates to the NCCN
Guidelines. J Natl Compr Cancer Netw. 11:531–546. 2013. View Article : Google Scholar
|
|
2
|
Gong J, Cao J, Liu G and Huo JR: Function
and mechanism of F-box proteins in gastric cancer (Review). Int J
Oncol. 47:43–50. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Singh S, Sharma B, Kanwar SS and Kumar A:
Lead phytochemicals for anticancer drug development. Front Plant
Sci. 7:16672016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hosseini A and Ghorbani A: Cancer therapy
with phytochemicals: Evidence from clinical studies. Avicenna J
Phytomed. 5:84–97. 2015.PubMed/NCBI
|
|
5
|
Chen QH, Fu ML, Chen MM, Liu J, Liu XJ, He
GQ and Pu SC: Preparative isolation and purification of xanthohumol
from hops (Humulus lupulus L.) by high-speed counter-current
chromatography. Food Chem. 132:619–623. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang B, Chu W, Wei P, Liu Y and Wei T:
Xanthohumol induces generation of reactive oxygen species and
triggers apoptosis through inhibition of mitochondrial electron
transfer chain complex I. Free Radic Biol Med. 89:486–497. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kunnimalaiyaan S, Sokolowski KM,
Balamurugan M, Gamblin TC and Kunnimalaiyaan M: Xanthohumol
inhibits Notch signaling and induces apoptosis in hepatocellular
carcinoma. PLoS One. 10:e01274642015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yoo YB, Park KS, Kim JB, Kang HJ, Yang JH,
Lee EK and Kim HY: Xanthohumol inhibits cellular proliferation in a
breast cancer cell line (MDA-MB231) through an intrinsic
mitochondrial-dependent pathway. Indian J Cancer. 51:518–523. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Benelli R, Venè R, Ciarlo M, Carlone S,
Barbieri O and Ferrari N: The AKT/NF-κB inhibitor xanthohumol is a
potent anti-lymphocytic leukemia drug overcoming chemoresistance
and cell infiltration. Biochem Pharmacol. 83:1634–1642. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Deeb D, Gao X, Jiang H, Arbab AS,
Dulchavsky SA and Gautam SC: Growth inhibitory and
apoptosis-inducing effects of xanthohumol, a prenylated chalone
present in hops, in human prostate cancer cells. Anticancer Res.
30:3333–3339. 2010.PubMed/NCBI
|
|
11
|
Festa M, Capasso A, DAcunto CW, Masullo M,
Rossi AG, Pizza C and Piacente S: Xanthohumol induces apoptosis in
human malignant glioblastoma cells by increasing reactive oxygen
species and activating MAPK pathways. J Nat Prod. 74:2505–2513.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Y, Fan S, Koo J, Yue P, Chen ZG,
Owonikoko TK, Ramalingam SS, Khuri FR and Sun SY: Elevated
expression of eukaryotic translation initiation factor 4E is
associated with proliferation, invasion and acquired resistance to
erlotinib in lung cancer. Cancer Biol Ther. 13:272–280. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen FZ, Mo XM, Wang QP, Li J and Zhang L:
Effects of rosiglitazone on the growth and lymphangiogenesis of
human gastric cancer transplanted in nude mice. Oncol Rep.
30:2705–2712. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zuo ZK, Gong Y, Chen XH, Ye F, Yin ZM,
Gong QN and Huang JS: TGFβ1-induced lncRNA UCA1 upregulation
promotes gastric cancer invasion and migration. DNA Cell Biol.
36:159–167. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tong XP, Ma YX, Quan DN, Zhang L, Yan M
and Fan XR: Rosemary extracts upregulate Nrf2, Sestrin2, and MRP2
protein level in human hepatoma HepG2 cells. Evid Based Complement
Alternat Med. 2017:73598062017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fouani L, Kovacevic Z and Richardson DR:
Targeting oncogenic nuclear factor kappa B signaling with
redox-active agents for cancer treatment. Antioxid Redox Signal.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
McAdam EL, Freeman JS, Whittock SP, Buck
EJ, Jakse J, Cerenak A, Javornik B, Kilian A, Wang CH, Andersen D,
et al: Quantitative trait loci in hop (Humulus lupulus L.) reveal
complex genetic architecture underlying variation in sex, yield and
cone chemistry. BMC Genom. 14:3602013. View Article : Google Scholar
|
|
18
|
Dostálek P, Karabín M and Jelínek L: Hop
phytochemicals and their potential role in metabolic syndrome
prevention and therapy. Molecules. 22:E17612017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zanoli P and Zavatti M: Pharmacognostic
and pharmacological profile of Humulus lupulus L. J Ethnopharmacol.
116:383–396. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nikolic D and van Breemen RB: Analytical
methods for quantitation of prenylated flavonoids from hops. Curr
Anal Chem. 9:71–85. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Verzele M, Stockx J, Fontijn F and
Anteunis M: Xanthohumol, a new natural chalkone. J Agric Food Chem.
66:452–475. 1957.
|
|
22
|
Liu M, Hansen PE, Wang G, Qiu L, Dong J,
Yin H, Qian Z, Yang M and Miao J: Pharmacological profile of
xanthohumol, a prenylated flavonoid from hops (Humulus lupulus).
Molecules. 20:754–779. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dorn C, Weiss TS, Heilmann J and
Hellerbrand C: Xanthohumol, a prenylated chalcone derived from
hops, inhibits proliferation, migration and interleukin-8
expression of hepatocellular carcinoma cells. Int J Oncol.
36:435–441. 2010.PubMed/NCBI
|
|
24
|
Sławińska-Brych A, Król SK,
Dmoszyńska-Graniczka M, Zdzisińska B, Stepulak A and Gagoś M:
Xanthohumol inhibits cell cycle progression and proliferation of
larynx cancer cells in vitro. Chem Biol Interact. 240:110–118.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yong WK, Ho YF and Malek SN: Xanthohumol
induces apoptosis and S phase cell cycle arrest in A549 non-small
cell lung cancer cells. Pharmacogn Mag. 11 Suppl 2:S275–S283. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hardwick JM and Soane L: Multiple
functions of BCL-2 family proteins. Cold Spring Harb Perspect Biol.
5:a0087222013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Obermannová R and Lordick F: Management of
metastatic gastric cancer. Hematol Oncol Clin North Am. 31:469–483.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sosa V, Moliné T, Somoza R, Paciucci R,
Kondoh H and ME LL: Oxidative stress and cancer: An overview.
Ageing Res Rev. 12:376–390. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Afzal S, Jensen SA, Sørensen JB, Henriksen
T, Weimann A and Poulsen HE: Oxidative damage to guanine
nucleosides following combination chemotherapy with 5-fluorouracil
and oxaliplatin. Cancer Chemother Pharmacol. 69:301–307. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Raj L, Ide T, Gurkar AU, Foley M, Schenone
M, Li X, Tolliday NJ, Golub TR, Carr SA, Shamji AF, et al:
Selective killing of cancer cells by a small molecule targeting the
stress response to ROS. Nature. 475:231–234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zou ZW, Liu T, Li Y, Chen P, Peng X, Ma C,
Zhang WJ and Li PD: Melatonin suppresses thyroid cancer growth and
overcomes radioresistance via inhibition of p65 phosphorylation and
induction of ROS. Redox Biol. 16:226–236. 2018. View Article : Google Scholar : PubMed/NCBI
|
